MX2019012840A - Metodo para tratar el trastorno de estres postraumatico. - Google Patents

Metodo para tratar el trastorno de estres postraumatico.

Info

Publication number
MX2019012840A
MX2019012840A MX2019012840A MX2019012840A MX2019012840A MX 2019012840 A MX2019012840 A MX 2019012840A MX 2019012840 A MX2019012840 A MX 2019012840A MX 2019012840 A MX2019012840 A MX 2019012840A MX 2019012840 A MX2019012840 A MX 2019012840A
Authority
MX
Mexico
Prior art keywords
stress disorder
traumatic stress
treating post
post
treating
Prior art date
Application number
MX2019012840A
Other languages
English (en)
Inventor
Hillel Glover
HAHN, (FINADO) Elliot
Original Assignee
Hillel Glover
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hillel Glover filed Critical Hillel Glover
Publication of MX2019012840A publication Critical patent/MX2019012840A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Heat Treatment Of Articles (AREA)
  • Heat Treatment Of Strip Materials And Filament Materials (AREA)

Abstract

Se da a conocer y se describe un procedimiento de ajuste de la dosis novedoso para administrar el antagonista de opioides, nalmefeno, a un paciente con diagnóstico de trastorno de estrés postraumático (TEPT).
MX2019012840A 2017-04-25 2018-04-25 Metodo para tratar el trastorno de estres postraumatico. MX2019012840A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762489501P 2017-04-25 2017-04-25
PCT/US2018/029257 WO2018200607A1 (en) 2017-04-25 2018-04-25 Method for treating post-traumatic stress disorder

Publications (1)

Publication Number Publication Date
MX2019012840A true MX2019012840A (es) 2020-07-20

Family

ID=63918674

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019012840A MX2019012840A (es) 2017-04-25 2018-04-25 Metodo para tratar el trastorno de estres postraumatico.

Country Status (8)

Country Link
US (1) US10987350B2 (es)
EP (1) EP3615012B1 (es)
JP (1) JP2020517730A (es)
AU (1) AU2018258337A1 (es)
CA (1) CA3061350A1 (es)
IL (1) IL270203B2 (es)
MX (1) MX2019012840A (es)
WO (1) WO2018200607A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028612A (en) * 1990-03-22 1991-07-02 Hillel Glover Method for treating emotional numbness
WO1997033581A1 (en) * 1996-03-13 1997-09-18 Yale University Smoking cessation treatments using naltrexone and related compounds
JP6479766B2 (ja) * 2013-04-17 2019-03-06 ハー・ルンドベック・アクチエゼルスカベット 不安障害患者の治療のためのナルメフェン

Also Published As

Publication number Publication date
EP3615012A1 (en) 2020-03-04
US20200197387A1 (en) 2020-06-25
WO2018200607A1 (en) 2018-11-01
IL270203B1 (en) 2023-07-01
EP3615012C0 (en) 2024-06-26
IL270203A (es) 2019-12-31
AU2018258337A1 (en) 2019-12-12
CA3061350A1 (en) 2018-11-01
US10987350B2 (en) 2021-04-27
IL270203B2 (en) 2023-11-01
EP3615012B1 (en) 2024-06-26
JP2020517730A (ja) 2020-06-18
EP3615012A4 (en) 2020-12-23

Similar Documents

Publication Publication Date Title
MX2017014191A (es) Metodos de tratamiento de una enfermedad neurodegenerativa.
MX2021008113A (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma.
MX2018012493A (es) Métodos para controlar y tratar el cáncer.
MX2020011772A (es) Terapia de combinacion que involucra anticuerpos contra claudina 18.2 para tratamiento de cancer.
SG10201901010PA (en) Combination therapy for treating a paramyxovirus
NZ730763A (en) Methods of treating a tauopathy
PH12017500933A1 (en) Sublingual administration of riluzole
MX2016000364A (es) Metodos para tratar o prevenir afecciones oftalmologicas.
TW201713333A (en) Methods of treating a neurodegenerative disease
PH12017500934A1 (en) Sublingual formulation of riluzole
EA201792209A1 (ru) Схема введения пропущенных доз инъекционных сложных эфиров палиперидона длительного действия
NZ722600A (en) Methods of treating mild brain injury
MA40535A (fr) Imagerie et thérapie d'une inflammation et d'une infection ciblant hsp90
WO2016133449A9 (en) Detection and treatment of malignant tumours in the cns
MX2018005085A (es) Nanoparticulas terapeuticas que comprenden un agente terapeutico y metodos de fabricacion y uso de las mismas.
MY175326A (en) Product and method for treating diarrhea
MX2017014436A (es) Compuestos biciclicos.
TW201613639A (en) Methods for treating cardiovascular diseases
MX2016016667A (es) Métodos para tratar el cáncer y prevenir la resistencia a fármacos contra el cáncer.
MX2018001684A (es) Metodo de curacion de heridas.
MX2019012840A (es) Metodo para tratar el trastorno de estres postraumatico.
MX2017016533A (es) Metodo para tratar glomeruloesclerosis focal y segmentaria primaria.
WO2017095918A3 (en) Methods for treating cancer using rspo3 antagonists
MX358512B (es) Uso de (r)-7cloro-n-(quinuclidin-3-il) benzo[b] tiofeno-2-carboxamida o una sal farmacéuticamente aceptable de la misma para preparar una composición farmacéutica en el tratamiento de una disfunción cognitiva.
PH12017501918A1 (en) Multi-peptide composition